News

FDA requiring lower starting dose for sleep drug Lunesta

FDA announced it required the manufacturer of the sleep drug Lunesta (eszopiclone) to change the drug label and lower the current recommended starting dose.

16th May 2014

For more information or an estimate, contact us »

Who we help: